Sujay Jadhav

Current Position

Title: Chief Executive Officer Company: Verana Health Location: San Francisco Bay Area

Professional Background

Sujay Jadhav is a seasoned healthcare technology executive with over 20 years of experience building and scaling enterprise software solutions in the life sciences sector. His career has been marked by consistent execution of high-impact acquisitions and strategic transitions, including leading goBalto (cloud-based clinical research platform) through its acquisition by Oracle in 2018-2019, where he subsequently served as Global Vice President of the Health Sciences Business Unit. Prior to goBalto, Jadhav spent 13+ years at Model N, joining as one of the company's earliest employees and rising to Senior Vice President of Global Corporate Strategy and Development while overseeing the company's IPO and growth from startup to $100M+ revenue organization.

At Verana Health, which he joined as CEO in August 2021, Jadhav is driving the company's evolution into a leader in real-world data (RWD) for clinical research. He has expanded the company's clinical trial capabilities, established strategic data-as-a-service offerings, developed medical society partnerships, and enhanced data quality through innovative product launches. His tenure has been marked by significant partnerships (HealthVerity collaboration in 2024) and expanded medical society integrations (American Urological Association partnership expansion).

Jadhav's strategic approach emphasizes the intersection of human expertise and artificial intelligence, viewing technology as an augmentation tool rather than replacement for clinical judgment. His background in both engineering and business development positions him uniquely to bridge technical innovation with commercial healthcare requirements.

Career Timeline

Education

• MBA, Harvard University
• Bachelor's degree in Electronic Engineering, University of South Australia

Public Presence

Social Media

Note: Only publicly accessible profiles are documented.

Published Writings

• "Augmenting Brain Power: Real-World Data, Advanced Analytics, and the Future of Clinical Trials" — MedCity News (2025)
• "2025 Trends: Using Unstructured Data in Clinical Research" — Applied Clinical Trials Online (2024)
• "The Evolution of Real-World Evidence: Moving Beyond Claims Data in Clinical Trials" — Applied Clinical Trials Online (October 2024)
• "How High-Quality, Curated Real-World Data from Clinical Data Registries Helps Improve Drug Trials" — Applied Clinical Trials Online (March 2024)
• "Patient Recruitment Reimagined: How AI is Key to Clinical Trial Acceleration" — MedCity News (2025)
• "Using Real World Data to Enhance Clinical Trials" — LinkedIn Pulse (April 2017)
• Multiple articles on AI integration, data quality, and synthetic control arms in clinical research

Public Speaking

• Panel discussant, Coyote Ventures 2025 Health Equity Innovators Fall Gathering (AI in healthcare and implications for Medicaid/Medi-Cal)
• Speaker, Carnegie Mellon University Make Possible Campaign Celebration Dinner
• Presenter at Piper Sandler Heartland Summit
• ISPE conference and pharmaceutical engineering community speaker

Communication Style

Tone: Measured optimism, pragmatic authority, educational clarity Recurring themes: Real-world data (RWD) quality and application; AI as augmentation (not replacement) for human expertise; clinical trial efficiency and patient recruitment; healthcare data equity and bias mitigation; intersection of technology and clinical integrity Notable positions: Strong advocate for human-in-the-loop AI approaches in healthcare; emphasis on data quality as prerequisite for AI effectiveness; champion of minority representation and equity in clinical trials and healthcare research

Jadhav communicates with professional authority grounded in deep operational experience rather than theoretical speculation. His writing style balances technical precision with accessibility—he explains complex concepts like "unstructured data" and "natural language processing" without jargon overload, making advanced topics comprehensible to diverse audiences. He frequently employs a "problem-solution-outcome" narrative structure, positioning challenges faced by the clinical research industry, then walking readers through how technology and human judgment can address them collaboratively. In interviews and articles, he references FDA guidance, real-world use cases, and concrete business metrics, establishing credibility through specificity rather than broad claims. His LinkedIn activity and speaking engagements reveal a leader who actively engages with industry trends (recently focusing on AI integration, data equity, and synthetic trial methodologies) while maintaining cautious optimism about technology's transformative potential. The consistent emphasis on "augmenting brain power" rather than replacing human expertise reflects his core philosophy: technology succeeds in healthcare only when it enhances rather than supplants clinical judgment and human oversight.

Notable Achievements

• Named PharmaVoice 100 winner in the Clinical Trial Pros category (2024)
• Led goBalto to acquisition by Oracle with 30%+ reduction in clinical trial startup times
• Built and scaled Model N's life sciences division; instrumental in company's IPO and growth to $100M+ revenue
• Expanded Verana Health's real-world data platform with new specialty modules (ophthalmology, urology)
• Established strategic partnerships advancing RWD accessibility (HealthVerity collaboration, medical society integrations)
• Launched innovative products including Qdata Explorer and new MIPS Advisory Services for life sciences research
• Employee #6 at Model N; contributed to growth from startup to public company with 600+ employees

Key Relationships

• Strategic partnership with HealthVerity (Preferred Data Partner Program, 2024)
• Partnership expansion with American Urological Association for AQUA Registry (2024-2025)
• Collaboration with World AI Forum (WAIFO), non-profit focused on AI serving humanity
• Professional affiliation with ISPE (International Society for Pharmaceutical Engineering)
• Active contributor to clinical research and healthcare technology communities through speaking and publications